The Food and Drug Administration's role in supporting therapeutic development to address unmet needs: the National Academies report and beyond
{{output}}
Despite substantial progress, many serious diseases continue to lack safe and effective therapies. Building on a recent National Academies consensus study report that offers several recommendations to better align investments in therapeutic development with un... ...
